Skip to content
10-K

Annual Report

CUMBERLAND PHARMACEUTICALS INC CPIX

0001087294-26-000020

← back to feed
Filed
Mar 9, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 4, 2026 14.96M sh
Shares Diluted FY 2025 · Dec 31, 2025 14.85M sh
Shares Diluted FY 2025 · Dec 31, 2024 14.06M sh
Stock Repurchased FY 2025 · Dec 31, 2025 $263.48K
Stock Repurchased FY 2025 · Dec 31, 2024 $579.05K
Capex FY 2025 · Dec 31, 2025 $97.9K
Capex FY 2025 · Dec 31, 2024 $66.46K
Operating Cash Flow FY 2025 · Dec 31, 2025 $4.93M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$612.19K
Short Term Debt FY 2025 · Dec 31, 2025 $0
Short Term Debt FY 2025 · Dec 31, 2024 $5.1M
Cash And Equivalents FY 2025 · Dec 31, 2025 $11.44M
Cash And Equivalents FY 2025 · Dec 31, 2024 $17.96M
Stockholders Equity FY 2025 · Dec 31, 2025 $24.88M
Stockholders Equity FY 2025 · Dec 31, 2024 $22.85M
Current Liabilities FY 2025 · Dec 31, 2025 $36.74M
Current Liabilities FY 2025 · Dec 31, 2024 $31.62M
Total Liabilities FY 2025 · Dec 31, 2025 $52.28M
Total Liabilities FY 2025 · Dec 31, 2024 $53.04M
Current Assets FY 2025 · Dec 31, 2025 $37.06M
Current Assets FY 2025 · Dec 31, 2024 $36.45M
Total Assets FY 2025 · Dec 31, 2025 $76.82M
Total Assets FY 2025 · Dec 31, 2024 $75.58M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.09
Eps Diluted FY 2025 · Dec 31, 2025 −$0.19
Eps Diluted FY 2025 · Sep 30, 2025 −$0.13
Eps Diluted FY 2025 · Jun 30, 2025 −$0.05
Eps Diluted FY 2025 · Mar 31, 2025 $0.08
Eps Diluted FY 2025 · Dec 31, 2024 −$0.46
Eps Basic FY 2025 · Dec 31, 2025 −$0.09
Eps Basic FY 2025 · Dec 31, 2025 −$0.19
Eps Basic FY 2025 · Sep 30, 2025 −$0.13
Eps Basic FY 2025 · Jun 30, 2025 −$0.05
Eps Basic FY 2025 · Mar 31, 2025 $0.08
Eps Basic FY 2025 · Dec 31, 2024 −$0.46
Sga Expense FY 2025 · Dec 31, 2025 $11.95M
Sga Expense FY 2025 · Dec 31, 2024 $11.13M
Rd Expense FY 2025 · Dec 31, 2025 $5.57M
Rd Expense FY 2025 · Dec 31, 2024 $4.82M
Net Income FY 2025 · Dec 31, 2025 −$1.41M
Net Income FY 2025 · Dec 31, 2025 −$2.84M
Net Income FY 2025 · Sep 30, 2025 −$1.94M
Net Income FY 2025 · Jun 30, 2025 −$740.74K
Net Income FY 2025 · Mar 31, 2025 $1.26M
Net Income FY 2025 · Dec 31, 2024 −$1.9M
Net Income FY 2025 · Dec 31, 2024 −$6.48M
Net Income FY 2025 · Sep 30, 2024 −$1.54M
Net Income FY 2025 · Jun 30, 2024 −$1.09M
Net Income FY 2025 · Mar 31, 2024 −$1.95M
Operating Income FY 2025 · Dec 31, 2025 −$1.37M
Operating Income FY 2025 · Dec 31, 2025 −$2.79M
Operating Income FY 2025 · Sep 30, 2025 −$1.97M
Operating Income FY 2025 · Jun 30, 2025 −$747.48K
Operating Income FY 2025 · Mar 31, 2025 $1.29M
Operating Income FY 2025 · Dec 31, 2024 −$1.84M
Operating Income FY 2025 · Dec 31, 2024 −$6.43M
Operating Income FY 2025 · Sep 30, 2024 −$1.69M
Operating Income FY 2025 · Jun 30, 2024 −$1.03M
Operating Income FY 2025 · Mar 31, 2024 −$1.87M
Cost Of Revenue FY 2025 · Dec 31, 2025 $6.67M
Cost Of Revenue FY 2025 · Dec 31, 2024 $6.59M
Revenue FY 2025 · Dec 31, 2025 $13.68M
Revenue FY 2025 · Dec 31, 2025 $44.52M
Revenue FY 2025 · Sep 30, 2025 $8.29M
Revenue FY 2025 · Jun 30, 2025 $10.84M
Revenue FY 2025 · Mar 31, 2025 $11.71M
Revenue FY 2025 · Dec 31, 2024 $10.44M
Revenue FY 2025 · Dec 31, 2024 $37.87M
Revenue FY 2025 · Sep 30, 2024 $9.09M
Revenue FY 2025 · Jun 30, 2024 $9.85M
Revenue FY 2025 · Mar 31, 2024 $8.5M